Carol Giltner Gallagher - Net Worth and Insider Trading

Carol Giltner Gallagher Net Worth

The estimated net worth of Carol Giltner Gallagher is at least $207,844 dollars as of 2024-11-10. Carol Giltner Gallagher is the Director of Atara Biotherapeutics Inc and owns about 18,377 shares of Atara Biotherapeutics Inc (ATRA) stock worth over $207,844. Details can be seen in Carol Giltner Gallagher's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Carol Giltner Gallagher has not made any transactions after 2023-11-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Carol Giltner Gallagher

To

Carol Giltner Gallagher Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Carol Giltner Gallagher owns 12 companies in total, including Metacrine Inc (MTCR) , Annexon Inc (ANNX) , and Millendo Therapeutics Inc (MLND) among others .

Click here to see the complete history of Carol Giltner Gallagher’s form 4 insider trades.

Insider Ownership Summary of Carol Giltner Gallagher

Ticker Comapny Transaction Date Type of Owner
MTCR Metacrine Inc 2020-09-15 director
ANNX Annexon Inc 2020-07-23 director
MLND Millendo Therapeutics Inc 2020-06-22 director
LIMIT LIMIT 2023-11-14 director
LIMIT LIMIT 2019-07-24 director
LIMIT LIMIT 2017-01-25 director
LIMIT LIMIT 2018-12-07 director
LIMIT LIMIT 2021-06-15 director
LIMIT LIMIT 2022-11-22 director
LIMIT LIMIT 2022-11-22 director
LIMIT LIMIT 2022-11-03 director
LIMIT LIMIT 2023-06-22 director

Carol Giltner Gallagher Latest Holdings Summary

Carol Giltner Gallagher currently owns a total of 1 stock. Carol Giltner Gallagher owns 18,377 shares of Atara Biotherapeutics Inc (ATRA) as of November 14, 2023, with a value of $207,844.

Latest Holdings of Carol Giltner Gallagher

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ATRA Atara Biotherapeutics Inc 2023-11-14 18,377 11.31 207,844

Holding Weightings of Carol Giltner Gallagher


Carol Giltner Gallagher Form 4 Trading Tracker

According to the SEC Form 4 filings, Carol Giltner Gallagher has made a total of 1 transactions in Atara Biotherapeutics Inc (ATRA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Atara Biotherapeutics Inc is the acquisition of 10,800 shares on November 14, 2023, which cost Carol Giltner Gallagher around $67,500.

Insider Trading History of Carol Giltner Gallagher

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Carol Giltner Gallagher Trading Performance

GuruFocus tracks the stock performance after each of Carol Giltner Gallagher's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Carol Giltner Gallagher is 121.45%. GuruFocus also compares Carol Giltner Gallagher's trading performance to market benchmark return within the same time period. The performance of stocks bought by Carol Giltner Gallagher within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Carol Giltner Gallagher's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Carol Giltner Gallagher

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 96.78 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 91.8 LIMIT LIMIT LIMIT LIMIT LIMIT

Carol Giltner Gallagher Ownership Network

Ownership Network List of Carol Giltner Gallagher

No Data

Ownership Network Relation of Carol Giltner Gallagher

Insider Network Chart

Carol Giltner Gallagher Owned Company Details

What does Metacrine Inc do?

Who are the key executives at Metacrine Inc?

Carol Giltner Gallagher is the director of Metacrine Inc. Other key executives at Metacrine Inc include Chief Business Officer Michael York , director & President & CEO Preston Klassen , and 10 percent owner Braden Michael Leonard .

Metacrine Inc (MTCR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Metacrine Inc (MTCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Metacrine Inc (MTCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Metacrine Inc (MTCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Metacrine Inc Insider Transactions

No Available Data

Carol Giltner Gallagher Mailing Address

Above is the net worth, insider trading, and ownership report for Carol Giltner Gallagher. You might contact Carol Giltner Gallagher via mailing address: C/o Atara Biotherapeutics, Inc., 3260 Bayshore Boulevard, Brisbane Ca 94005.